UNASSIGNED: Asthma affects an estimated 7 million @entity1 and causes significant health care and disease burden. The most recent iteration of the National Heart, Lung and Blood Institute @entity565 guidelines, the Expert Panel Report 3, emphasizes the assessment and monitoring of @entity565 control in the management of @entity565 . Asthma control refers to the degree to which the manifestations of @entity565 are minimized by therapeutic interventions and the goals of therapy are met. Although assessment of @entity565 severity is used to guide initiation of therapy, monitoring of @entity565 control helps determine whether therapy should be maintained or adjusted. The nuances of estimation of @entity565 control include understanding concepts of current @entity73 and incorporating their measurement into clinical practice. Impairment is assessed on the basis of frequency and intensity of symptoms, variations in lung function, and limitations of daily activities. "Risk" refers to the likelihood of exacerbations, progressive @entity393 , or adverse effects from medications. Currently available ambulatory tools to measure @entity565 control range are subjective measures, such as @entity1 -reported composite @entity565 control score instruments or objective measures of lung function, @entity1224 , and biomarkers. Because @entity565 control exhibits short- and long-term variability, health care providers need to be vigilant regarding the fluctuations in the factors that can create discordance between subjective and objective assessment of @entity565 control. Familiarity with the properties, application, and relative value of these measures will enable health care providers to choose the optimal set of measures that will adhere to national standards of care and ensure delivery of high-quality care customized to their @entity1 .

Clinical Tools to Assess Asthma Control in XXXX .

@entity1 :: ('9606', 'Species') :: ['children', 'patients', 'patient'] @entity565 :: ('MESH:D001249', 'Disease') :: ['asthma'] @entity73 :: ('MESH:D003072', 'Disease') :: ['impairment and future risk'] @entity393 :: ('MESH:D034381', 'Disease') :: ['loss of lung function'] @entity1224 :: ('MESH:D000402', 'Disease') :: ['airway hyperreactivity']
@entity1 :: (9606,Species) :: ['Children']
